Stroke Circulatory System
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Participant has been recruited into the SLSR. Criteria for inclusion into the SLSR are: 1.1. Confirmed stroke (cerebral ischaemic stroke, primary intracerebral haemorrhage, subarachnoid haemorrhage, and stroke not known if ischaemic or haemorrhagic); people with asymptomatic cerebrovascular disease or those with scan-negative TIA are not included in the SLSR. 1.2. Main residence of participants is in the SLSR study area at the time of first stroke (27 electoral wards in the northern part of Lambeth and Southwark; participant’s residence within these wards is confirmed by postcode) 1.3. First stroke since 1st January 1995 1.4. Age at first stroke: 18 years or older 2. Participant is due for a routine 3-month to 5-year SLSR follow-up over a 12-month period following the study start date 3. Participant has the capacity to consent to take part in the study 4. Participant has sufficient proficiency in English (currently there is only an English version of the patient portal 5. Participant has given consent to be contacted by the SLSR team for further stroke-related research
Exclusion criteria
Exclusion criteria: 1. SLSR participants who lack the mental capacity to consent will not be included in this study. 2. Non-English speakers will not be included in this feasibility study as there is currently only an English version of this patient portal. Later work might involve offering different language versions. This limitation will need to be considered when interpreting the results of this feasibility study. 3. People residing in a social care setting will be excluded in order to not put a potential additional burden on the care team.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Portal utilisation: number of log-ins, time spent on the portal and navigation history per participant over the 6-month follow-up 2. Rates of completion of EQ-5D-5L scale questionnaires online over the 6-month follow-up 3. Quality of life measured using EQ-5D-5L scale over the 6-month follow-up 4. Rates of recording of home BP (for those with BP self-management module) over the 6-month follow-up 5. BP measurements taken by participants and entered on the portal over the 6-month follow-up 6. Proportion of participants and time spent accessing the BP self-measurement training video over the 6-month follow-up 7. Intervention acceptability and satisfaction and decisional conflict, assessed via semi-structured interviews at the 6-month follow-up visit, quantitatively through Likert scales and qualitative interview analysis 8. Chronic disease self-efficacy measured using the Self-Efficacy for Managing Chronic Disease 6-item Scale at the 6-month follow-up visit | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The number, duration, and reasons of interactions (email or telephone) between the participant/carer and the study team for support with portal usage over the 6-month follow-up 2. Health and social care service use in the previous 6 months, collected through a 6-month participant follow-up interview 3. Portal maintenance costs measured using the number of researcher hours utilised at the end of study data collection 4. Administrative costs: BP monitors and tablets, delivery and return of devices, postage costs, expenses for field worker travel measured using itemised costs and number of researcher hours utilised at the end of study data collection | — |
Countries
England, United Kingdom
Contacts
;